Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction

BACKGROUND: Malignant bowel obstruction (MBO) affects 3–15% of all cancer patients. In patients with advanced cancer and inoperable MBO, the average survival varies between four to nine weeks. Parenteral nutrition (PN) may improve survival in specific patient populations with malignant bowel obstruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Velasquez, David A., Dhiman, Ankit, Brottman, Colette, Eng, Oliver S., Fenton, Emily, Herlitz, Jean, Lozano, Edward, McDonald, Edwin, Reynolds, Valerie, Wall, Elizabeth, Whitridge, Jeffrey, Semrad, Carol, Turaga, Kiran, Micic, Dejan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680932/
https://www.ncbi.nlm.nih.gov/pubmed/38014195
http://dx.doi.org/10.21203/rs.3.rs-3455273/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680932/
https://www.ncbi.nlm.nih.gov/pubmed/38014195
http://dx.doi.org/10.21203/rs.3.rs-3455273/v1

Ejemplares similares